Vertex Pharmaceuticals’ third quarter was marked by steady double-digit revenue growth, yet the market responded negatively ...

Q3 2025 Earnings Call Transcript November 3, 2025 Vertex, Inc. reports earnings inline with expectations. Reported EPS is ...

Good morning, everyone. My name is Dina Elmonshed, one of the U.S. biotech analysts here at UBS. And joining me today is the President and CEO of Vertex Pharmaceuticals, Reshma Kewalramani. Thank you ...

The market has since validated Guo’s conviction. On Kickstarter, Zettlab raised more than USD 1.4 million, with 80% of ...

Good day, and welcome to the Vertex Inc. Third Quarter 2025 Earnings Conference Call. [Operator Instructions] Please note that this conference is being recorded. I would now like to turn the ...

Expert-Backed Tips For Regowing Your Hair This article was reviewed by Knox Beasley, MD. Ask the internet how to get thicker ...

(RTTNews) - Vertex Pharmaceuticals Inc. (VRTX) presented new interim data for its investigational therapy povetacicept (pove) in IgA nephropathy (IgAN) and primary membranous nephropathy (pMN) at the ...

One of the most common genetic diseases, AATD, involves the retention of misfolded alpha 1 antitrypsin (AAT) in hepatocytes, ...

We’ve sifted through early Black Friday offers to highlight the best vacuum deals we’ve come across so far, so you can find a high-performing model without the premium price tag. Our favorite upright ...

Sullivan might be best known for launching the Lumber Liquidators chain. But this week he's raising money for another cause.

With immunology and inflammation blockbusters like AbbVie’s Skyrizi and Rinvoq reeling in nearly $7 billion combined in the ...